YU-CHI TUNGChang G.-M.KUO-LIONG CHIENYU-KANG TU2020-05-192020-05-1920140025-7079https://www.scopus.com/inward/record.uri?eid=2-s2.0-84901366498&doi=10.1097%2fMLR.0000000000000132&partnerID=40&md5=adbe146a1661b62698e0450f7431d612https://scholars.lib.ntu.edu.tw/handle/123456789/493692BACKGROUNDEnglish[SDGs]SDG3acetylsalicylic acid; beta adrenergic receptor blocking agent; hydroxymethylglutaryl coenzyme A reductase inhibitor; adult; aged; article; cardiologist; cardiovascular mortality; female; high volume hospital; human; low volume hospital; major clinical study; male; medical care; percutaneous coronary intervention; physician; priority journal; sensitivity analysis; ST segment elevation myocardial infarction; Taiwan; university hospital; Adrenergic beta-Antagonists; Aged; Angioplasty, Balloon, Coronary; Aspirin; Cause of Death; Coronary Artery Bypass; Female; Guideline Adherence; Health Facility Size; Hospital Mortality; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interdisciplinary Communication; Male; Middle Aged; Myocardial Infarction; National Health Programs; Outcome and Process Assessment (Health Care); Physician's Practice Patterns; Taiwanjournal article10.1097/MLR.0000000000000132247839912-s2.0-84901366498